Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Rhabdoid Tumor 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Etoposide 30 Carboplatin 29 atezolizumab 17 durvalumab 16 Cisplatin 14 Topotecan 11 Specimen Handling 9 PM 01183 9 Magnetic Resonance Spectroscopy 7 pembrolizumab 6 olaparib 5 berzosertib 4 anlotinib 4 Radiotherapy 4 Nivolumab 4 Irinotecan 4 Drug Therapy 4 tremelimumab 3 toripalimab 3 tislelizumab 3 Paclitaxel 3 Injections 3 Docetaxel 3 Biopsy 3 Bevacizumab 3 AMG 757 3 sacituzumab govitecan 2 monalizumab 2 cabozantinib 2 Temozolomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × MLN 8237 × 90 days × Clear all

NCT06095505 2026-06-05

ALISCA-Lung1

Puma Biotechnology, Inc.

Phase 2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡